TipRanks
Go Ultimate55% OFF

Eastgate Biotech (ETBI) Financial Statements

Eastgate Biotech Financial Overview

Eastgate Biotech's market cap is currently $11.29M. The company's EPS TTM is $-0.01; its P/E ratio is -2.63; Eastgate Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 19Dec 18Dec 17
Income Statement
Total Revenue$ 99.73K$ 136.13K$ 157.38K
Gross Profit$ -110.08K$ -68.88K$ -3.04K
Operating Income$ -3.27M$ -1.35M$ -3.43M
EBITDA$ -3.10M$ -1.23M$ -3.33M
Net Income$ -3.54M$ -1.50M$ -3.72M
Balance Sheet
Cash & Short-Term Investments$ 10.19K$ 4.40K$ 15.81K
Total Assets$ 1.28M$ 1.38M$ 1.63M
Total Debt$ 4.50M$ 3.95M$ 3.13M
Net Debt$ 4.49M$ 3.95M$ 3.11M
Total Liabilities$ 10.96M$ 9.11M$ 7.35M
Stockholders' Equity$ -9.68M$ -7.73M$ -5.72M
Cash Flow
Free Cash Flow$ 60.18K$ -258.16K$ -1.44M
Operating Cash Flow$ 113.76K$ -258.16K$ -1.40M
Investing Cash Flow$ -53.57K$ 0.00$ -47.61K
Financing Cash Flow$ 551.90K$ 701.48K$ 1.59M

Currency in USD

Eastgate Biotech Earnings and Revenue History

-4M-2M02M-4500 %-3000 %-1500 %0 %EarningsProfit Margin201720182019RevenueEarningsProfit Margin

Eastgate Biotech Debt to Assets

04M8M12M400 %600 %800 %1000 %LiabilitiesDebt to Assets201720182019AssetsLiabilitiesDebt to Assets

Eastgate Biotech Cash Flow

-2M-1M01M2M201720182019OperatingInvestingFinancing

Eastgate Biotech Forecast EPS vs Actual EPS